CYTH Annual Net Income
-$20.06 M
-$4.61 M-29.81%
31 December 2023
Summary:
As of January 23, 2025, CYTH annual net profit is -$20.06 million, with the most recent change of -$4.61 million (-29.81%) on December 31, 2023. During the last 3 years, it has fallen by -$11.12 million (-124.31%). CYTH annual net income is now -3168.74% below its all-time high of $653.60 thousand, reached on December 31, 2007.CYTH Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CYTH Quarterly Net Income
-$8.83 M
-$2.85 M-47.68%
30 September 2024
Summary:
As of January 23, 2025, CYTH quarterly net profit is -$8.83 million, with the most recent change of -$2.85 million (-47.68%) on September 30, 2024. Over the past year, it has dropped by -$3.19 million (-56.55%). CYTH quarterly net income is now -1884.06% below its all-time high of $495.10 thousand, reached on December 31, 2007.CYTH Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CYTH TTM Net Income
-$24.80 M
-$4.06 M-19.58%
30 September 2024
Summary:
As of January 23, 2025, CYTH TTM net profit is -$24.80 million, with the most recent change of -$4.06 million (-19.58%) on September 30, 2024. Over the past year, it has dropped by -$4.74 million (-23.64%). CYTH TTM net income is now -3894.90% below its all-time high of $653.50 thousand, reached on December 31, 2007.CYTH TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CYTH Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -29.8% | -56.5% | -23.6% |
| 3 y3 years | -124.3% | -56.5% | -23.6% |
| 5 y5 years | -371.4% | -56.5% | -23.6% |
CYTH Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -40.4% | at low | -218.7% | at low | -92.6% | at low |
| 5 y | 5-year | -166.3% | at low | -515.3% | at low | -229.2% | at low |
| alltime | all time | -3168.7% | at low | -1884.1% | at low | -3894.9% | at low |
Cyclo Therapeutics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$8.83 M(+47.7%) | -$24.80 M(+19.6%) |
| June 2024 | - | -$5.98 M(+37.7%) | -$20.74 M(+6.9%) |
| Mar 2024 | - | -$4.34 M(-23.0%) | -$19.39 M(-3.3%) |
| Dec 2023 | -$20.06 M(+29.8%) | -$5.64 M(+18.3%) | -$20.06 M(+3.4%) |
| Sept 2023 | - | -$4.77 M(+2.9%) | -$19.40 M(+2.8%) |
| June 2023 | - | -$4.64 M(-7.4%) | -$18.87 M(+6.7%) |
| Mar 2023 | - | -$5.01 M(+0.5%) | -$17.69 M(+14.5%) |
| Dec 2022 | -$15.45 M(+8.1%) | -$4.98 M(+17.3%) | -$15.45 M(+16.5%) |
| Sept 2022 | - | -$4.25 M(+23.0%) | -$13.26 M(+3.0%) |
| June 2022 | - | -$3.45 M(+24.5%) | -$12.88 M(-1.1%) |
| Mar 2022 | - | -$2.77 M(-0.7%) | -$13.02 M(-8.9%) |
| Dec 2021 | -$14.29 M(+59.8%) | -$2.79 M(-27.7%) | -$14.29 M(+0.8%) |
| Sept 2021 | - | -$3.86 M(+7.3%) | -$14.17 M(+20.6%) |
| June 2021 | - | -$3.60 M(-10.9%) | -$11.75 M(+13.6%) |
| Mar 2021 | - | -$4.04 M(+50.6%) | -$10.34 M(+15.7%) |
| Dec 2020 | -$8.94 M(+18.7%) | -$2.68 M(+86.7%) | -$8.94 M(+0.5%) |
| Sept 2020 | - | -$1.44 M(-34.5%) | -$8.90 M(-2.1%) |
| June 2020 | - | -$2.19 M(-16.8%) | -$9.09 M(+10.0%) |
| Mar 2020 | - | -$2.63 M(-0.0%) | -$8.26 M(+9.7%) |
| Dec 2019 | -$7.53 M(+77.0%) | -$2.63 M(+62.1%) | -$7.53 M(+20.3%) |
| Sept 2019 | - | -$1.63 M(+18.8%) | -$6.26 M(+15.4%) |
| June 2019 | - | -$1.37 M(-28.2%) | -$5.43 M(+1.5%) |
| Mar 2019 | - | -$1.90 M(+39.4%) | -$5.35 M(+25.6%) |
| Dec 2018 | -$4.25 M(+11.0%) | -$1.37 M(+73.5%) | -$4.25 M(-0.4%) |
| Sept 2018 | - | -$787.30 K(-38.9%) | -$4.27 M(+3.7%) |
| June 2018 | - | -$1.29 M(+58.6%) | -$4.12 M(+12.6%) |
| Mar 2018 | - | -$812.90 K(-41.3%) | -$3.66 M(-4.6%) |
| Dec 2017 | -$3.83 M(-9.2%) | -$1.38 M(+118.4%) | -$3.83 M(+16.8%) |
| Sept 2017 | - | -$633.70 K(-23.4%) | -$3.28 M(-23.0%) |
| June 2017 | - | -$827.80 K(-16.2%) | -$4.26 M(-5.4%) |
| Mar 2017 | - | -$987.50 K(+18.7%) | -$4.51 M(+6.7%) |
| Dec 2016 | -$4.22 M(+65.5%) | -$832.00 K(-48.5%) | -$4.22 M(-5.0%) |
| Sept 2016 | - | -$1.61 M(+50.8%) | -$4.45 M(+24.2%) |
| June 2016 | - | -$1.07 M(+51.8%) | -$3.58 M(+24.8%) |
| Mar 2016 | - | -$705.80 K(-33.1%) | -$2.87 M(+12.4%) |
| Dec 2015 | -$2.55 M(+330.5%) | -$1.06 M(+41.2%) | -$2.55 M(+40.7%) |
| Sept 2015 | - | -$747.60 K(+107.6%) | -$1.81 M(+40.9%) |
| June 2015 | - | -$360.20 K(-7.2%) | -$1.29 M(+19.4%) |
| Mar 2015 | - | -$388.30 K(+22.4%) | -$1.08 M(+81.9%) |
| Dec 2014 | -$592.70 K(-389.3%) | -$317.30 K(+43.6%) | -$592.70 K(+64.7%) |
| Sept 2014 | - | -$220.90 K(+45.9%) | -$359.80 K(+54.2%) |
| June 2014 | - | -$151.40 K(-256.2%) | -$233.40 K(-228.5%) |
| Mar 2014 | - | $96.90 K(-214.8%) | $181.70 K(-11.3%) |
| Dec 2013 | $204.90 K(+176.1%) | -$84.40 K(-10.7%) | $204.90 K(-51.2%) |
| Sept 2013 | - | -$94.50 K(-135.8%) | $419.90 K(-10.4%) |
| June 2013 | - | $263.70 K(+119.6%) | $468.70 K(+215.4%) |
| Mar 2013 | - | $120.10 K(-8.0%) | $148.60 K(+100.0%) |
| Dec 2012 | $74.20 K | $130.60 K(-385.8%) | $74.30 K(-157.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2012 | - | -$45.70 K(-19.0%) | -$128.60 K(-3.7%) |
| June 2012 | - | -$56.40 K(-223.1%) | -$133.60 K(+219.6%) |
| Mar 2012 | - | $45.80 K(-163.3%) | -$41.80 K(-57.3%) |
| Dec 2011 | -$97.80 K(+160.8%) | -$72.30 K(+42.6%) | -$97.80 K(-345.7%) |
| Sept 2011 | - | -$50.70 K(-243.2%) | $39.80 K(-25.6%) |
| June 2011 | - | $35.40 K(-447.1%) | $53.50 K(+22.1%) |
| Mar 2011 | - | -$10.20 K(-115.6%) | $43.80 K(-216.8%) |
| Dec 2010 | -$37.50 K(-80.6%) | $65.30 K(-276.5%) | -$37.50 K(-88.5%) |
| Sept 2010 | - | -$37.00 K(-244.0%) | -$326.80 K(+27.1%) |
| June 2010 | - | $25.70 K(-128.1%) | -$257.10 K(-12.4%) |
| Mar 2010 | - | -$91.50 K(-59.2%) | -$293.40 K(+15.1%) |
| Dec 2009 | -$193.10 K(-53.3%) | -$224.00 K(-785.0%) | -$254.90 K(-31.0%) |
| Sept 2009 | - | $32.70 K(-408.5%) | -$369.50 K(-7.8%) |
| June 2009 | - | -$10.60 K(-80.0%) | -$400.60 K(+0.4%) |
| Mar 2009 | - | -$53.00 K(-84.3%) | -$398.90 K(-3.5%) |
| Dec 2008 | -$413.20 K(-163.2%) | -$338.60 K(<-9900.0%) | -$413.20 K(-198.3%) |
| Sept 2008 | - | $1600.00(-118.0%) | $420.50 K(-14.0%) |
| June 2008 | - | -$8900.00(-86.8%) | $488.90 K(-16.1%) |
| Mar 2008 | - | -$67.30 K(-113.6%) | $582.90 K(-10.8%) |
| Dec 2007 | $653.60 K(-742.0%) | $495.10 K(+607.3%) | $653.50 K(+313.6%) |
| Sept 2007 | - | $70.00 K(-17.7%) | $158.00 K(+514.8%) |
| June 2007 | - | $85.10 K(+2478.8%) | $25.70 K(-132.7%) |
| Mar 2007 | - | $3300.00(-925.0%) | -$78.50 K(-22.9%) |
| Dec 2006 | -$101.80 K(-41.0%) | -$400.00(-99.4%) | -$101.80 K(-75.8%) |
| Sept 2006 | - | -$62.30 K(+226.2%) | -$421.20 K(-2.9%) |
| June 2006 | - | -$19.10 K(-4.5%) | -$433.60 K(+10.3%) |
| Mar 2006 | - | -$20.00 K(-93.7%) | -$393.00 K(+127.8%) |
| Dec 2005 | -$172.50 K(-69.3%) | -$319.80 K(+328.1%) | -$172.50 K(+75.1%) |
| Sept 2005 | - | -$74.70 K(-447.4%) | -$98.50 K(+688.0%) |
| June 2005 | - | $21.50 K(-89.3%) | -$12.50 K(-96.3%) |
| Mar 2005 | - | $200.50 K(-181.6%) | -$333.70 K(-40.6%) |
| Dec 2004 | -$561.50 K(-306.7%) | -$245.80 K(-2275.2%) | -$561.60 K(+594.2%) |
| Sept 2004 | - | $11.30 K(-103.8%) | -$80.90 K(+25.2%) |
| June 2004 | - | -$299.70 K(+993.8%) | -$64.60 K(-125.3%) |
| Mar 2004 | - | -$27.40 K(-111.7%) | $255.70 K(-5.9%) |
| Dec 2003 | $271.70 K(+64.1%) | $234.90 K(+751.1%) | $271.70 K(+3475.0%) |
| Sept 2003 | - | $27.60 K(+34.0%) | $7600.00(-88.9%) |
| June 2003 | - | $20.60 K(-280.7%) | $68.50 K(-31.9%) |
| Mar 2003 | - | -$11.40 K(-61.0%) | $100.60 K(-39.3%) |
| Dec 2002 | $165.60 K(-245.4%) | -$29.20 K(-133.0%) | $165.60 K(+2.6%) |
| Sept 2002 | - | $88.50 K(+67.9%) | $161.40 K(+707.0%) |
| June 2002 | - | $52.70 K(-1.7%) | $20.00 K(-161.3%) |
| Mar 2002 | - | $53.60 K(-260.5%) | -$32.60 K(-71.4%) |
| Dec 2001 | -$113.90 K(-63.7%) | -$33.40 K(-36.9%) | -$113.90 K(-40.2%) |
| Sept 2001 | - | -$52.90 K(<-9900.0%) | -$190.40 K(-7.3%) |
| June 2001 | - | $100.00(-100.4%) | -$205.40 K(-0.0%) |
| Mar 2001 | - | -$27.70 K(-74.8%) | -$205.50 K(+15.6%) |
| Dec 2000 | -$313.40 K | -$109.90 K(+61.9%) | -$177.80 K(+161.9%) |
| Sept 2000 | - | -$67.90 K | -$67.90 K |
FAQ
- What is Cyclo Therapeutics annual net profit?
- What is the all time high annual net income for Cyclo Therapeutics?
- What is Cyclo Therapeutics annual net income year-on-year change?
- What is Cyclo Therapeutics quarterly net profit?
- What is the all time high quarterly net income for Cyclo Therapeutics?
- What is Cyclo Therapeutics quarterly net income year-on-year change?
- What is Cyclo Therapeutics TTM net profit?
- What is the all time high TTM net income for Cyclo Therapeutics?
- What is Cyclo Therapeutics TTM net income year-on-year change?
What is Cyclo Therapeutics annual net profit?
The current annual net income of CYTH is -$20.06 M
What is the all time high annual net income for Cyclo Therapeutics?
Cyclo Therapeutics all-time high annual net profit is $653.60 K
What is Cyclo Therapeutics annual net income year-on-year change?
Over the past year, CYTH annual net profit has changed by -$4.61 M (-29.81%)
What is Cyclo Therapeutics quarterly net profit?
The current quarterly net income of CYTH is -$8.83 M
What is the all time high quarterly net income for Cyclo Therapeutics?
Cyclo Therapeutics all-time high quarterly net profit is $495.10 K
What is Cyclo Therapeutics quarterly net income year-on-year change?
Over the past year, CYTH quarterly net profit has changed by -$3.19 M (-56.55%)
What is Cyclo Therapeutics TTM net profit?
The current TTM net income of CYTH is -$24.80 M
What is the all time high TTM net income for Cyclo Therapeutics?
Cyclo Therapeutics all-time high TTM net profit is $653.50 K
What is Cyclo Therapeutics TTM net income year-on-year change?
Over the past year, CYTH TTM net profit has changed by -$4.74 M (-23.64%)